S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 146.1 SEK Market Closed
Market Cap: 7.5B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Surgical Science Sweden AB
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Revenue
kr859.8m
CAGR 3-Years
60%
CAGR 5-Years
58%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Revenue
kr18.1B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Revenue
kr737.2m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
13%
Getinge AB
STO:GETI B
Revenue
kr31.8B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Revenue
kr11B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Revenue
kr487.4m
CAGR 3-Years
41%
CAGR 5-Years
25%
CAGR 10-Years
20%
No Stocks Found

Surgical Science Sweden AB
Glance View

Market Cap
7.5B SEK
Industry
Health Care

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2017-06-19. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.

SUS Intrinsic Value
178.56 SEK
Undervaluation 18%
Intrinsic Value
Price
S

See Also

What is Surgical Science Sweden AB's Revenue?
Revenue
859.8m SEK

Based on the financial report for Sep 30, 2024, Surgical Science Sweden AB's Revenue amounts to 859.8m SEK.

What is Surgical Science Sweden AB's Revenue growth rate?
Revenue CAGR 5Y
58%

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Surgical Science Sweden AB have been 60% over the past three years , 58% over the past five years .

Back to Top